LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
36.71
+2.71 (7.97%)
At close: Oct 15, 2026, 4:00 PM EDT
36.69
-0.02 (-0.05%)
After-hours: Oct 15, 2026, 7:30 PM EDT
LB Pharmaceuticals Market Cap
LB Pharmaceuticals has a market cap or net worth of $1.18 billion as of October 15, 2026. It is the 9,222nd most valuable company in the world and the 2,124th biggest in the United States. Its market cap has increased by 237.63% in one year.
Market Cap
1.18B
Enterprise Value
861.02M
1-Year Change
237.63%
Global Rank
Country Rank
#2,124 United States
Category
ChartMarket Cap Chart
Since the IPO on September 11, 2025, LB Pharmaceuticals's market cap has increased from $301.50M to $1.18B, an increase of 292.56%. That is a compound annual growth rate of 249.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 1.18B | 110.17% |
| Dec 31, 2025 | 563.16M | 86.78% |
| Sep 11, 2025 | 301.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| First Tracks Biotherapeutics | 1.19B |
| ORIC Pharmaceuticals | 1.19B |
| Kardigan | 1.17B |
| Taysha Gene Therapies | 1.16B |
| Bicara Therapeutics | 1.15B |
| Damora Therapeutics | 1.13B |
| Vor Biopharma | 1.12B |
| Nanobiotix | 1.12B |